Neuropsychopharmacology
- Therapeutic effects of extinction require hippocampal input and BDNF signaling in IL11 months ago
- Punishment-resistant alcohol intake is mediated by the nucleus accumbens shell in female rats12 months ago
- Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants12 months ago
- Human neuroimaging and antipsychotic neurobiology at millisecond temporal resolution12 months ago
- Neuroimaging and suicide-specific stimuli12 months ago
- A novel fluorescently labelled ligand for the detection of DAT in immune cells by flow cytometry12 months ago
- Sex differences in sensitivity to dopamine receptor manipulations of risk-based decision making in rats12 months ago
Journal of Psychopharmacology
- Comparative efficacy of quetiapine by dose and formulation for psychosis in schizophrenia: A systematic review and dose–response model-based network meta-analysis2 years ago
- Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study2 years ago
- Predicting clozapine dose required to achieve a therapeutic plasma concentration – A comparison of a population algorithm and three algorithms based on gene variant models2 years ago
- Psilocybin history, action and reaction: A narrative clinical review2 years ago
- Fluoxetine rescues the depressive-like behaviour induced by reserpine and the altered emotional behaviour induced by nicotine withdrawal in zebrafish: Involvement of tyrosine hydroxylase2 years ago
- Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study2 years ago
- The risk of chronic psychedelic and MDMA microdosing for valvular heart disease2 years ago
European Neuropsychopharmacology
- Substance P, NPY, CCK and their receptors in five brain regions in major depressive disorder with transcriptomic analysis of locus coeruleus neurons2 years ago
- Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study2 years ago
- Pro-social and pro-cognitive effects of LIT-001, a novel oxytocin receptor agonist in a neurodevelopmental model of schizophrenia2 years ago
- Unlocking the enigma: Metabolic risks of typical antipsychotics and their link to COVID-19 mortality2 years ago
- Digital behavioural signatures reveal trans-diagnostic clusters of Schizophrenia and Alzheimer’s disease patients2 years ago
- Pharmacological anti-inflammatory treatment in children and adolescents with depressive symptoms: A systematic-review and meta-analysis2 years ago
- Methodological concerns in psychedelic research: The issues of nonequivalent psychological support and generalizability2 years ago